Skip to main content
Log in

Direct, Quantitative, and Noninvasive Imaging of the Transport of Active Agents Through Intact Brain with Positron Emission Tomography

  • Research Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Purpose

Our goal was to use positron emission tomography (PET) to analyze the movement of radiolabeled agents in tissue to enable direct measurement of drug delivery to the brain.

Procedures

Various 11C- and 18 F-labeled compounds were delivered directly to an agarose phantom or rat striatum. Concentration profiles were extracted for analysis and fitted to diffusion models.

Results

Diffusion coefficients ranged from 0.075 ± 0.0026 mm2/min ([18 F]fluoride ion, 18 Da) to 0.0016 ± 0.0018 mm2/min ([18 F]NPB4-avidin, 68 kDa) and matched well with predictions based on molecular weight (R 2 = 0.965). The tortuosity of the brain extracellular space was estimated to be 1.56, with the tissue clearance halftime of each tracer in the brain varying from 19 to 41 min.

Conclusions

PET is an effective modality to directly quantify the movement of locally delivered drugs or drug carriers. This continuous, noninvasive assessment of delivery will aid the design of better drug delivery methods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Krewson CE, Klarman ML, Saltzman WM (1995) Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res 680:196–206

    Article  PubMed  CAS  Google Scholar 

  2. Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2:3–14

    Article  PubMed  Google Scholar 

  3. Kreuter J (2001) Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65–81

    Article  PubMed  CAS  Google Scholar 

  4. Neeves KB, Sawyer AJ, Foley CP, Saltzman WM, Olbricht WL (2007) Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles. Brain Res 1180:121–132

    Article  PubMed  CAS  Google Scholar 

  5. Tiwari SB, Amiji MM (2006) A review of nanocarrier-based CNS delivery systems. Curr Drug Deliv 3:219–232

    Article  PubMed  CAS  Google Scholar 

  6. Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH (1999) Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg 90:315–320

    Article  PubMed  CAS  Google Scholar 

  7. Neeves KB, Lo CT, Foley CP, Saltzman WM, Olbricht WL (2006) Fabrication and characterization of microfluidic probes for convection enhanced drug delivery. J Control Release 111:252–262

    Article  PubMed  CAS  Google Scholar 

  8. Langer R (2001) Drug delivery. Drugs on target. Science 293:58–59

    Article  PubMed  CAS  Google Scholar 

  9. Gash DM, Zhang Z, Ai Y, Grondin R, Coffey R, Gerhardt GA (2005) Trophic factor distribution predicts functional recovery in parkinsonian monkeys. Ann Neurol 58:224–233

    Article  PubMed  CAS  Google Scholar 

  10. Peterson AL, Nutt JG (2008) Treatment of Parkinson’s disease with trophic factors. Neurotherapeutics 5:270–280

    Article  PubMed  CAS  Google Scholar 

  11. Salvatore MF, Ai Y, Fischer B et al (2006) Point source concentration of GDNF may explain failure of phase II clinical trial. Exp Neurol 202:497–505

    Article  PubMed  CAS  Google Scholar 

  12. Chen W, Cao Y, Liu M et al (2012) Rotavirus capsid surface protein VP4-coated Fe(3)O(4) nanoparticles as a theranostic platform for cellular imaging and drug delivery. Biomaterials 33:7895–7902

    Article  PubMed  CAS  Google Scholar 

  13. Chertok B, Moffat BA, David AE et al (2008) Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29:487–496

    Article  PubMed  CAS  Google Scholar 

  14. Janib SM, Moses AS, MacKay JA (2010) Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 62:1052–1063

    Article  PubMed  CAS  Google Scholar 

  15. Kim JH, Astary GW, Nobrega TL et al (2012) Dynamic contrast-enhanced MRI of Gd-albumin delivery to the rat hippocampus in vivo by convection-enhanced delivery. J Neurosci Methods 209:62–73

    Article  PubMed  CAS  Google Scholar 

  16. Zheng M, Sirianni R, Patel T et al (2010) [18F]PEG-biotin labeled nanoparticles for tracking drug delivery and tumor therapy. J Nucl Med 52:417

    Google Scholar 

  17. Polson A, van der RD (1950) Relationship between diffusion constants and molecular weight. Biochim Biophys Acta 5:358–360

    Article  PubMed  CAS  Google Scholar 

  18. Nicholson C, Phillips JM (1981) Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum. J Physiol 321:225–257

    PubMed  CAS  Google Scholar 

  19. Sykova E, Nicholson C (2008) Diffusion in brain extracellular space. Physiol Rev 88:1277–1340

    Article  PubMed  CAS  Google Scholar 

  20. Chen ZJ, Gillies GT, Broaddus WC et al (2004) A realistic brain tissue phantom for intraparenchymal infusion studies. J Neurosurg 101:314–322

    Article  PubMed  Google Scholar 

  21. Nicholson C, Tao L (1993) Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging. Biophys J 65:2277–2290

    Article  PubMed  CAS  Google Scholar 

  22. Maaloum M, Pernodet N, Tinland B (1998) Agarose gel structure using atomic force microscopy: gel concentration and ionic strength effects. Electrophoresis 19:1606–1610

    Article  PubMed  CAS  Google Scholar 

  23. Laske DW, Morrison PF, Lieberman DM et al (1997) Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg 87:586–594

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge the contributions of the staff of the Yale PET Center, including Maria Corsi, Krista Fowles, Jim Ropchan, Patrick Ouellette, and Nancy Nishimura for their technical assistance. This work was supported by National Institutes of Health grant, T32DA022975, “Neuroimaging Sciences Training Program” and was also made possible by CTSA Grant Number UL1RR024139 from the National Center for Research Resources and the National Center for Advancing Translational Science, components of the National Institutes of Health (NIH), and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.

Conflict of Interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rachael W. Sirianni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sirianni, R.W., Zheng, MQ., Saltzman, W.M. et al. Direct, Quantitative, and Noninvasive Imaging of the Transport of Active Agents Through Intact Brain with Positron Emission Tomography. Mol Imaging Biol 15, 596–605 (2013). https://doi.org/10.1007/s11307-013-0636-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-013-0636-9

Key words

Navigation